Private Wealth Management Group’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$31.7K Hold
251
0.01% 292
2026
Q1
$35K Sell
251
-3
-1% -$420 0.01% 237
2025
Q4
$31.2K Sell
254
-2
-0.8% -$243 0.01% 251
2025
Q3
$28.4K Hold
256
0.01% 261
2025
Q2
$28.4K Sell
256
-4
-2% -$426 0.01% 239
2025
Q1
$29.1K Sell
260
-13
-5% -$1.34K 0.01% 233
2024
Q4
$25.2K Buy
273
+48
+21% +$4.32K 0.01% 258
2024
Q3
$18.9K Buy
225
+7
+3% +$534 0.01% 301
2024
Q2
$15K Sell
218
-106
-33% -$7.07K 0.01% 347
2024
Q1
$23.7K Sell
324
-32
-9% -$2.46K 0.01% 240
2023
Q4
$28.8K Buy
+356
New +$27.7K 0.01% 218

Other funds holding GILD

Private Wealth Management Group's GILD Position: Q2 2026 in Review

Private Wealth Management Group held its Gilead Sciences (GILD) position steady in Q2 2026 at 251 shares worth $31.7K. The position accounts for 0.01% of the portfolio, ranked #292.

Private Wealth Management Group first reported a position in GILD in Q4 2023 and has held it in 11 quarters since. The position peaked at $35K in Q1 2026. 2,268 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Private Wealth Management Group held 251 shares of Gilead Sciences worth $31.7K as of Q2 2026.
  • Private Wealth Management Group left its Gilead Sciences share count unchanged in Q2 2026.
  • Gilead Sciences made up 0.01% of Private Wealth Management Group's portfolio in Q2 2026, its #292 holding.
  • Private Wealth Management Group first reported a position in Gilead Sciences in Q4 2023 and has held it in 11 quarters since.
  • Private Wealth Management Group's Gilead Sciences position peaked at $35K in Q1 2026.
  • 2,268 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Private Wealth Management Group's 13F filing for Q2 2026, filed 27 Jul 2026.